Skip to main content
Fig. 2 | Journal of Ovarian Research

Fig. 2

From: UBE2T regulates epithelial–mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer

Fig. 2

A High expression of UBE2T (low-power field) in ovarian serous adenocarcinoma. UBE2T, ubiquitin-binding enzyme E2T. B High expression of UBE2T (high-power field) in ovarian serous adenocarcinoma. UBE2T, ubiquitin-binding enzyme E2T. C Low expression of UBE2T (low-power field) in ovarian serous adenocarcinoma. UBE2T, ubiquitin-binding enzyme E2T. D Low expression of UBE2T (high-power field) in ovarian serous adenocarcinoma. UBE2T, ubiquitin-binding enzyme E2T. E and F Protein expression of UBE2T in ovarian cancer cell lines. UBE2T, ubiquitin-binding enzyme E2T. G Expression of UBE2T mRNA in ovarian cancer cell lines. UBE2T, ubiquitin-binding enzyme E2T

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us